Literature DB >> 7905099

Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours.

A H Heagerty1, D Fitzgerald, A Smith, B Bowers, P Jones, A A Fryer, L Zhao, J Alldersea, R C Strange.   

Abstract

Multiple allelism at loci encoding detoxicating enzymes is associated with cancer risk. We have studied genetic variation at the glutathione S-transferase GSTM1 locus to see whether phenotypes confer altered susceptibility to basal cell carcinoma (BCC), squamous cell carcinoma (SCC), malignant melanoma (MM), or multiple skin tumours of different histological types. The frequency of GSTM1 null in cases and controls (52%) was similar, except for patients with two or more tumours of different types (71%, p = 0.033). GSTM1 A/B was reduced in frequency (p < 0.05) in patients with single or multiple BCC. Thus GSTM1 A/B may be protective, and effectiveness of detoxication may be a factor determining susceptibility to skin cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7905099     DOI: 10.1016/s0140-6736(94)91115-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

1.  Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population.

Authors:  Soya Sisy Sam; Vinod Thomas; K S Reddy; Gopalakrishnan Surianarayanan; Adithan Chandrasekaran
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-10       Impact factor: 4.553

2.  The association of GSTM1 and GSTT1 polymorphisms with squamous cell carcinoma of cervix in Pakistan.

Authors:  Sarah Hasan; Abdul Hameed; Saima Saleem; S M Shahid; Ghulam Haider; Abid Azhar
Journal:  Tumour Biol       Date:  2015-02-09

3.  Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients.

Authors:  J T Lear; B B Tan; A G Smith; W Bowers; P W Jones; A H Heagerty; R C Strange; A A Fryer
Journal:  J R Soc Med       Date:  1997-07       Impact factor: 5.344

4.  Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A.

Authors:  A Inskip; J Elexperu-Camiruaga; N Buxton; P S Dias; J MacIntosh; D Campbell; P W Jones; L Yengi; J A Talbot; R C Strange
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

5.  Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis.

Authors:  J Hull; A H Thomson
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

6.  ASIP genetic variants and the number of non-melanoma skin cancers.

Authors:  Wen Lin; Abrar A Qureshi; Peter Kraft; Hongmei Nan; Qun Guo; Frank B Hu; Majken K Jensen; Jiali Han
Journal:  Cancer Causes Control       Date:  2011-01-09       Impact factor: 2.506

7.  Glutathione S-transferase and cytochrome P450 genotypes as risk factors for laryngeal carcinoma.

Authors:  V Jahnke; R Strange; C Matthias; A Fryer
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

8.  Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.

Authors:  Valérie Chaudru; M T Lo; F Lesueur; C Marian; H Mohamdi; K Laud; M Barrois; A Chompret; M F Avril; F Demenais; B Bressac-de Paillerets
Journal:  Fam Cancer       Date:  2009-05-31       Impact factor: 2.375

9.  Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk.

Authors:  Selena Palma; Flavia Novelli; Luca Padua; Aldo Venuti; Grazia Prignano; Luciano Mariani; Renata Cozzi; Donatella Tirindelli; Antonella Testa
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-13       Impact factor: 4.553

Review 10.  Chronic pancreatitis and cystic fibrosis.

Authors:  H Witt
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.